2017 American Transplant Congress
Effect of Statins on Influenza Vaccine Antibody Concentrations in Lung Transplant Recipients.
Background: Large population studies have shown that statin use at the time of influenza immunization is associated with lower antibody concentrations and decreased vaccine efficacy.…2017 American Transplant Congress
Improving Vaccination Rates for Lung Transplant Candidates.
In 2015, transplant pharmacists at the University of Chicago identified an opportunity to improve vaccination rates for transplant candidates. On 10/1/15, a pharmacist-led program was…2017 American Transplant Congress
MMR and Varicella Immunity After Pediatric Liver Transplant.
1Baylor College of Medicine, Houston; 2Texas Children's Hospital, Houston
Background: Children listed for liver transplantation (LT) are at risk for decreased vaccine response due to age, underlying disease, or waning immunity. Live attenuated vaccines…2017 American Transplant Congress
Successful Implementation of a Pneumococcal Vaccination Program for Pediatric Kidney Transplant Recipients.
Medical University of South Carolina, Charleston
Vaccine preventable diseases remain a serious problem among transplanted patients. Many children remain under vaccinated after a kidney transplant because of a lack of physician…2017 American Transplant Congress
Impact of a Pharmacist-Led Vaccine Recommendation Program for Pediatric Kidney Transplant Candidates.
Pediatric transplant recipients commonly have a deficient immunization status at the time of transplantation. Utilizing transplant pharmacists to improve these immunization rates has not previously…2017 American Transplant Congress
Spousal Transmission of Hepatitis B from a Hepatitis B Core Antibody Positive Liver Transplant Recipient – A Case Report.
University of Maryland Medical Center, Baltimore, MD
IntroductionGiven the shortage of donor organs, hepatitis B core antibody positive (HBcAb+) donors have been utilized to increase access to transplantation. It is well established…2017 American Transplant Congress
Efficacy and Safety of ASP0113 versus Placebo in CMV-Seronegative Kidney Transplant Patients Receiving an Organ from a CMV-Seropositive Donor.
Introduction: ASP0113 is a first-in-class DNA-based vaccine in development for the prevention of human cytomegalovirus (CMV) infection in at-risk hematopoietic cell transplant and solid organ…2017 American Transplant Congress
Influenza Viral Dynamics in a Large Cohort of Transplant Patients with Natural Influenza Infection.
Background:Influenza infection significantly impacts transplant patients. Despite this, there are limited data on how virological characteristics, including influenza viral load (VL), impact the outcome of…2017 American Transplant Congress
T Cell Responses to Viral Peptide Stimulation Predict Influenza Vaccine-Induced Seroconversion in Pediatric Solid Organ Transplant Recipients.
Introduction: Biomarkers predictive of vaccine response are needed to determine the optimal timing of immunization post-transplantation. We previously found that low T-cell ELISPOT responses to…2017 American Transplant Congress
ASP0113 Elicits an Immune Response in CMV-Seronegative Dialysis Patients: Comparison to Healthy Subjects.
Introduction: ASP0113 is a first-in-class, DNA-based vaccine in development for the prevention of CMV infection in at-risk hematopoietic cell transplant.Methods: A Phase 1, single-blind, parallel-group,…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- 18
- Next Page »